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ABSTRAK 
 
Adenokarsinoma papilari-viloglandular telah pertama kali dihuraikan oleh Young dan Scully 
pada tahun 1989 sebagai suatu entiti tersendiri dengan ciri-ciri histologi seperti 
pertumbuhan eksofitik, struktur vilus dan papilari serta atipia nukleus yang sedikit ke 
sederhana. Kami melaporkan satu kes adenokarsinoma papilari-viloglandular serviks 
dengan metastasis ke nodus limfa dan mengkajisemula ciri-ciri klinikopatologi enam kes 
yang telah dilaporkan. Pesakit ini merupakan kes ketujuh dengan ciri-ciri yang sama 
seperti kes-kes yang telah dilaporkan. Umur ketujuh-tujuh pesakit adalah diantara 29 
hingga 54 tahun (min, 41). Diantara tujuh kes ini, lima mempunyai invasi limfovaskular. 
Semua kecuali pesakit ketujuh telah dirawat dengan histerektomi radikal dan radioterapi. 
Jagaan susulan pesakit ketujuh adalah 7 bulan, malangnya beliau  telah meninggal dunia 
akibat infeksi respiratori. 
 
Kata kunci: adenokarsinoma papilari viloglandular, adenokarsinoma, serviks 
 
 
ABSTRACT 
 
Villoglandular papillary adenocarcinoma was first described by Young and Scully in 1989 
as a distinct entity with the histological features of exophytic growth proliferation, villous 
and papillary architecture and mild to moderate nuclear atypia. We report one case of 
villoglandular papillary adenocarcinoma (VGPA) of the uterine cervix with lymph node 
metastasis and reviewed the clinicopathological features of six other cases reported in the 
literature. Our patient is the seventh similar reported cases. They ranged in age from 29 to 
54 (mean, 41) years. Five had lymphovascular invasion. All except our patient were treated 
with radical hysterectomy and radiotherapy. She was followed-up for 7 months and 
unfortunately died due to chest infection. 
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INTRODUCTION 
 
Adenocarcinomas account for 10–20% of 
invasive cervical carcinomas (Young RH et 
al 1990). Young and Scully (1989) first 
described a new subset of cervical 
adenocarcinoma that was designated as 
‘‘villoglandular papillary adenocarcinoma 
(VGPA) of the uterine cervix’’ in 1989. The 
histological features of VGPA are exophytic 
growth, papillary architecture and mild to 
moderate cellular atypia. It has been 
reported as a distinctive histological 
subtype which developed in relatively 
young women (33-52 years old) and has a 
favourable prognosis (Young RH et al 
1989, Hopson L et al 1990, Jones MW et al 
1993, Reed W et al 1993, Costa MJ et al 
1995). Approximately 80 cases of VGPA 
have been reported in the literature (Young 
RH et al 1989, Jones MW et al 1993, Kaku 
T et al 1997, Stanley-Christian H et al 
1997, Khunamrnpong S et al 2001). Its 
incidence has been quoted as 3.7-4.8% of 
the adenocarcinoma of the cervix (Garcea 
A et al 2003). There are only six cases of 
VGPA with lymph node metastasis 
reported in the literature, of which five 
showed lymphatic space permeation in the 
main tumour (Kaku T et al 1997, Utsugi K 
et al 2002, Khunamornpong S et al 2001, 
Garcea A et al 2003). We report a case of 
VGPA with right obturator lymph node 
metastasis and a review of the six similar 
cases reported in literature. 
 
 
CASE REPORT 
 
A 45-year-old multigravid Malay housewife 
presented with a one week history of 
generalised abdominal pain, which was 
intermittent, sharp stabbing in nature and 
aggravated by inspiration. She had two full 
term spontaneous vaginal deliveries that 
were antenatally uneventful. She was a 
known diabetic and hypertensive on 
metformin and prazosin for the past eight 
years. She never had a pap smear done. 
There was no family history of 
gynecological malignancy, smoking or 
alcohol consumption. There was no history 
of oral contraceptive usage. 
She was pale, and weighed 67 
kilograms. Systemic examinations were 
unremarkable. Cervical examination 
revealed a nodular exophytic, friable, 
hemorrhagic growth, arising from the 
posterior wall of the cervix, measuring 2.0 
cm in diameter. A piece of the tissue 
detached during manipulation. A biopsy 
was obtained, with the clinical impression 
of cervical carcinoma stage IB.  
Microscopically, the cervical biopsy 
specimen was composed of fragments of 
polypoidal tissues with villous and papillary 
fronds arranged in complex branching 
pattern. The papillae were lined by 
glandular epithelium displaying mild to 
moderate nuclear atypia (Figure 1). Mitotic 
figure count was brisk (90/10 high power 
field). Lymphovascular invasion was not 
present. 
She was planned for a Wertheim 
hysterectomy, however, during the 
operation, frozen section detected right 
obturator lymph node metastasis (Figure 
2). Wertheim hysterectomy was 
abandoned due to the advanced disease, 
instead, a bilateral salphingoophrectomy, 
myomectomy for leiomyoma and right iliac 
and obturator lymphadenectomy were 
performed. She also received 30 doses of 
external radiotherapy with concurrent 
chemotherapy of five cycles of weekly 
cisplatin. Unfortunately she died seven 
months after the surgery due to chest 
infection. 
 
 
A synopsis of the clinicopathological 
features of villoglandular papillary adeno-
carcinoma of uterine cervix with lymph 
node metastasis in the literature 
 
There are approximately 80 cases of 
VGPA ever reported in the literature. Of 
these, six cases presented with lymph 
node metastasis (7.5%). A synopsis of the 
clinicopathological features of the above 
six cases together with our present case is 
listed in table 1. The ages ranged from 29 
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Figure 1: Exophytic tumour composed of villous and papillary architecture (H&E, 10x 
magnification) 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.  Histological section of the right obturator lymph node showing infiltration by 
metastatic adenocarcinoma (H&E stain, 20x magnification). 
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Table 1: Clinicopathological features of reported cases of villoglandular papillary 
adenocarcinoma with lymph node metastasis 
 
Case Author Age Clinical 
presentation 
Stage LVI Lynph node 
metastasis 
Mitotic 
figure 
count 
Treatment Follow 
up 
Outcome 
1 Kaku T et al 
1997 
(2 cases) 
54 Abnormal 
uterine 
bleeding 
IIB Positive Positive (Right 
obturator lymph 
Node) 
- RAH with ERT 46 
months 
DOD 
2  33 Abnormal 
uterine 
bleeding 
IB Positive Positive (Left 
external iliac and 
left obturator 
lymph node) 
- RAH with ERT 10 
months 
NED 
3 Utsugi K et al 
2002 
48 Genital 
bleeding and 
vaginal 
discharge 
IIB Positive Positive (Right 
external iliac 
lymph node, left 
external iliac 
lymph 
nodes, and 
obturator lymph 
nodes) 
105/10 
HPF 
 
Wertheim 
hysterectomy with 
pelvic 
lymphadenectomy 
and bilateral 
adenexectomy 
 with whole pelvic 
irradiation 
17 
years 
NED 
4-5 Khunamornpong 
S et al 2001 
(2 cases) 
- - IB-IIA Positive Positive - RAH with ERT 21-144 
months 
NED 
6 Garcea A et al 
2003 
29 Postcoital 
bleed 
IIB Negative Positive (Right 
obturator lymph 
node) 
- RAH with ERT 34 
months 
NED 
7 Present case 45 Abdominal 
pain 
IB Negative Positive (Right 
obturator lymph 
node) 
90/10 
HPF 
Bilateral 
salphingoophrectomy 
and 
lymphadenectomy 
with ERT and 
chemotherapy 
7 
months 
Died of 
Chest 
Infection 
 
DOD - Died of disease, NED - No evidence of disease, RAH - Radical hysterectomy,    
ERT - External radiation therapy, LVI - Lymphovascular invasion, HPF - High power field 
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to 54 years (mean, 41 years). The clinical 
presentation includes abnormal uterine 
bleeding (43%), vaginal discharge (14%), 
postcoital bleeding (14%) and abdominal 
pain (14%). Five cases had 
lymphovascular invasion (71%). The 
obturator lymph node (100%) is the 
commonest site of metastasis, with greater 
propensity towards the right side, followed 
by the external iliac lymph node (40%). The 
mitotic figure count reported by Utsugi K et 
al (2002) and the present case were 
105/10HPF and 90/10HPF, respectively. 
All cases were followed up between seven 
months to 17 years, of which two died 
(28.6%), one due to the disease and the 
other because of chest infection. 
 
DISCUSSION 
 
Villoglandular papillary adenocarcinoma is 
a distinct entity and rare histological variant 
of cervical adenocarcinoma, which is 
believed to have a favourable prognosis 
and predominantly develops in young 
women with oral contraceptive use (Young 
RH et al 1989, Jones MW et al 1993). 
Young and Scully (1989) described a case 
of oral contraceptive use in their 13 cases 
of VGPA. Later, Jones et al (1993) 
demonstrated a statistically significant 
difference in the incidence of oral 
contraceptive use in five of the 24 VGPA. 
Other published series showed no 
consistent association between oral 
contraceptive use and villoglandular 
papillary adenocarcinoma, hence it 
remains debatable (Garcea A et al 1988). 
The three important histopathological 
features of VGPA are 1) an exophytic 
growth pattern, 2) papillary architecture 
and 3) mild to moderate nuclear atypia. 
The epithelium can be a mixture of 
endometrial, endocervical and intestinal 
differentiation. The differential diagnosis of 
VGPA includes 1) serous papillary 
adenocarcinoma in which complex papillae 
lined by markedly atypical nuclei with high 
mitotic activity are present, 2) endocervical 
adenocarcinoma with a minor villoglandular 
component, and 3) minimal deviation 
adenocarcinoma, with a diffusely infiltrative 
growth pattern and absence of cytologic 
atypia. 
Young and Scully (1989) mentioned that 
VGPA should be reserved for those 
tumours composed exclusively or almost 
exclusively of villoglandular papillary 
pattern (Young RH et al 1989). Various 
authors have reported the association of 
other patterns, for example squamous cell 
carcinoma (Kaku T et al 1997), small cell 
carcinoma (Van Nagell JR et al 1988) and 
adenocarcinoma in situ (Jones MW et al 
1993). Hence, a thorough search for 
coexistence of a different malignancy such 
as squamous cell carcinoma, small cell 
carcinoma, etc. is mandatory. 
In most malignancies, the tumour size, 
depth of invasion, lymphovascular invasion 
and lymph node metastasis are considered 
histological risk factors for recurrence. 
Utsugi K et al (2002) tried to determine the 
relationship between mitotic figure counts 
with incidence of lymph node metastasis. 
They found a significant difference in 
mitotic figure count of 105/10HPF in their 
patient with lymph node metastasis, as 
compared with 12 other patients without 
lymph node metastasis where the median 
mitotic figure count was 28/10 HPF (range 
between 4-70/10 HPF) (Utsugi K et al 
2002). The mitotic figure count for our 
patient is 90/10 HPF, which supports this 
observation. 
Various reports recommend 
conservative management, i.e. a cone 
biopsy, after a careful review of the 
histopathological findings (Young RH et al 
1989, Jones MW et al 1993). We 
emphasise that a careful search for any 
lymphovascular invasion, coexistence of a 
different tumour such as squamous cell 
carcinoma or small cell carcinoma and 
mitotic figure count be carried out, and 
when present, they should be included in 
the histopathological report. These should 
be considered as poor prognostic factors 
for VGPA.  
All the seven VGPA cases with lymph 
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node metastases received radiotherapy 
and after a range of follow up of seven 
months to 17 years, six of the seven cases 
(86%) showed no evidence of disease. 
Although the number of cases is too small 
to give any conclusive comments, VGPA 
with lymph node metastases seems to 
have a better outcome after radical 
hysterectomy followed by radiotherapy and 
chemotherapy. 
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